| Authors: |
Lin KH; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Xie A; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Rutter JC; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Ahn YR; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Lloyd-Cowden JM; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Nichols AG; Department of Pediatrics, Duke University Medical Center, Durham, NC, USA., Soderquist RS; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA., Koves TR; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA., Muoio DM; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA., MacIver NJ; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA; Department of Pediatrics, Duke University Medical Center, Durham, NC, USA., Lamba JK; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA., Pardee TS; Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest Baptist Health, Winston-Salem, NC, USA., McCall CM; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Rizzieri DA; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Wood KC; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA. Electronic address: kris.wood@duke.edu. |
